Literature DB >> 17624713

Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer.

R Persiani1, S Rausei, A Biondi, S Boccia, F Cananzi, D D'Ugo.   

Abstract

AIMS: No consensus exists on the level and number of lymph nodes to be dissected and examined for accurate staging of patients with resectable gastric cancer. The aim of this study was to examine the prognostic value and staging accuracy of the metastatic lymph nodes ratio (NR).
METHODS: The postoperative survival of 247 patients with gastric cancer who underwent gastrectomy was analyzed. Lymph nodes status was assigned according to three different classifications: 6th UICC/AJCC TNM; JGCA; NR (NR0: 0%; NR1: < or =20%; NR2: >20%). Staging accuracy of the three classifications was compared according to patients survival.
RESULTS: A significant difference in survival was observed in patients with NR1 versus NR2. At multivariate analysis only NR along with pT and grading were found to be independent prognostic factors. Stage migration was present in 84 cases (51%) with JGCA classification, in 30 (19%) with 6th UICC/AJCC TNM classification and in only 18 cases (11%) when NR was applied.
CONCLUSIONS: Our data showed that NR is a simply reproducible and highly reliable staging system with a strong ability to predict patients' outcome. Compared to other nodal staging classifications, NR is less influenced from the number of the lymph nodes dissected and examined, reducing the stage migration phenomenon.

Entities:  

Mesh:

Year:  2007        PMID: 17624713     DOI: 10.1016/j.ejso.2007.05.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  33 in total

1.  Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy.

Authors:  Chang-Ming Huang; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Bi-Juan Lin; Jia-Bin Wang
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

2.  Metastatic lymph node ratio: a new staging system for gastric cancer.

Authors:  Roberto Persiani; Stefano Rausei; Vincenzo Antonacci; Alberto Biondi; Francesco Casella; Luigi Ciccoritti; Domenico D'Ugo
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

3.  Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.

Authors:  Ahmet Bilici; Mesut Seker; Bala Basak Oven Ustaalioglu; Burcak Yilmaz; Alper Doventas; Taflan Salepci; Mahmut Gumus
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

4.  Moving from lymph node metastasis in gastric cancer to biological markers: reply to letter.

Authors:  Naoto Fukuda
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

5.  Limited lymph node dissection and metastatic lymph node ratio: a wave of trust.

Authors:  Alberto Biondi; Roberto Persiani; Ferdinando Cananzi; Marco Zoccali; Andrea Tufo; Domenico D'Ugo
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

6.  Diagnostic accuracy of dual-energy CT-based nomograms to predict lymph node metastasis in gastric cancer.

Authors:  Jing Li; Mengjie Fang; Rui Wang; Di Dong; Jie Tian; Pan Liang; Jie Liu; Jianbo Gao
Journal:  Eur Radiol       Date:  2018-06-04       Impact factor: 5.315

7.  Comparison of four staging systems of lymph node metastasis in gastric cancer.

Authors:  Ming Zhang; Guanyu Zhu; Yan Ma; Yingwei Xue
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

8.  Prognostic significance of the metastatic lymph node ratio in gastric cancer patients.

Authors:  Naoto Fukuda; Yasuyuki Sugiyama; Akira Midorikawa; Hiroyuki Mushiake
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

9.  Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer.

Authors:  Wafi Attaallah; Kivilcim Uprak; Omer Gunal; Cumhur Yegen
Journal:  Indian J Surg Oncol       Date:  2016-01-09

10.  Gastric cancer: predictors of recurrence when lymph-node dissection is inadequate.

Authors:  Esther Uña
Journal:  World J Surg Oncol       Date:  2009-09-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.